SMG
IDNA icon

Spectrum Management Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Spectrum Management Group’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2K Hold
82
– – ﹤0.01% 231
2022
Q2 		$2K Hold
82
– – ﹤0.01% 233
2022
Q1 		$3K Buy
+82
New +$2.9K ﹤0.01% 302

Other funds holding IDNA

WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Spectrum Management Group's IDNA Position: Q3 2022 in Review

Spectrum Management Group held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q3 2022 at 82 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #231.

Spectrum Management Group first reported a position in IDNA in Q1 2022 and has held it in 3 quarters since. The position peaked at $3K in Q1 2022. 67 funds tracked by Wall St. Rank hold IDNA as of Q3 2022.

  • Spectrum Management Group held 82 shares of iShares Genomics Immunology and Healthcare ETF worth $2K as of Q3 2022.
  • Spectrum Management Group left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q3 2022.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Spectrum Management Group's portfolio in Q3 2022, its #231 holding.
  • Spectrum Management Group first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2022 and has held it in 3 quarters since.
  • Spectrum Management Group's iShares Genomics Immunology and Healthcare ETF position peaked at $3K in Q1 2022.
  • 67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2022.

Based on Spectrum Management Group's 13F filing for Q3 2022, filed 1 Nov 2022.